MAPK1 and head and neck squamous cell carcinoma: To investigate whether inhibition of Erk phosphorylation is required for the activity of CYH33 in HNSCC cells, the level of phosphorylated Erk in sensitive and resistant cells upon CYH33 treatment was examined.